Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma

The worldwide incidence of head and neck cancer (HNC) exceeds half a million cases annually, and up to half of the patients with HNC present with advanced disease. Surgical resection remains the mainstay of treatment for many HNCs, although radiation therapy, chemotherapy, targeted therapy, and immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuran, Rui, Xiaoqing, Li, Danni, Wang, Yanhong, Tan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560126/
https://www.ncbi.nlm.nih.gov/pubmed/36249012
http://dx.doi.org/10.3389/fonc.2022.994172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560126/
https://www.ncbi.nlm.nih.gov/pubmed/36249012
http://dx.doi.org/10.3389/fonc.2022.994172

Ejemplares similares